206 related articles for article (PubMed ID: 17942939)
1. Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70.
Chang CL; Tsai YC; He L; Wu TC; Hung CF
Cancer Res; 2007 Oct; 67(20):10047-57. PubMed ID: 17942939
[TBL] [Abstract][Full Text] [Related]
2. alpha-Galactosylceramide enhances the protective and therapeutic effects of tumor cell based vaccines for ovarian tumors.
Choi YS; Hoory T; Monie A; Wu A; Connolly D; Hung CF
Vaccine; 2008 Oct; 26(46):5855-63. PubMed ID: 18771701
[TBL] [Abstract][Full Text] [Related]
3. Control of human mesothelin-expressing tumors by DNA vaccines.
Chang CL; Wu TC; Hung CF
Gene Ther; 2007 Aug; 14(16):1189-98. PubMed ID: 17581599
[TBL] [Abstract][Full Text] [Related]
4. A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma.
Yuan J; Kashiwagi S; Reeves P; Nezivar J; Yang Y; Arrifin NH; Nguyen M; Jean-Mary G; Tong X; Uppal P; Korochkina S; Forbes B; Chen T; Righi E; Bronson R; Chen H; Orsulic S; Brauns T; Leblanc P; Scholler N; Dranoff G; Gelfand J; Poznansky MC
J Hematol Oncol; 2014 Feb; 7():15. PubMed ID: 24565018
[TBL] [Abstract][Full Text] [Related]
5. Control of mesothelin-expressing ovarian cancer using adoptive transfer of mesothelin peptide-specific CD8+ T cells.
Hung CF; Tsai YC; He L; Wu TC
Gene Ther; 2007 Jun; 14(12):921-9. PubMed ID: 17377599
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene.
Cheng WF; Hung CF; Chai CY; Hsu KF; He L; Rice CM; Ling M; Wu TC
J Immunol; 2001 May; 166(10):6218-26. PubMed ID: 11342644
[TBL] [Abstract][Full Text] [Related]
7. Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors.
Kim D; Hoory T; Monie A; Wu A; Hsueh WT; Pai SI; Hung CF
J Biomed Sci; 2010 Jul; 17(1):61. PubMed ID: 20659328
[TBL] [Abstract][Full Text] [Related]
8. Enhanced generation of cytotoxic T lymphocytes by heat shock protein 70 fusion proteins harboring both CD8(+) T cell and CD4(+) T cell epitopes.
Takemoto S; Nishikawa M; Guan X; Ohno Y; Yata T; Takakura Y
Mol Pharm; 2010 Oct; 7(5):1715-23. PubMed ID: 20695521
[TBL] [Abstract][Full Text] [Related]
9. HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice.
Manjili MH; Wang XY; Chen X; Martin T; Repasky EA; Henderson R; Subjeck JR
J Immunol; 2003 Oct; 171(8):4054-61. PubMed ID: 14530326
[TBL] [Abstract][Full Text] [Related]
10. High-affinity interactions between peptides and heat shock protein 70 augment CD8+ T lymphocyte immune responses.
Flechtner JB; Cohane KP; Mehta S; Slusarewicz P; Leonard AK; Barber BH; Levey DL; Andjelic S
J Immunol; 2006 Jul; 177(2):1017-27. PubMed ID: 16818758
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors.
Wu CY; Yang HY; Monie A; Ma B; Tsai HH; Wu TC; Hung CF
Cancer Immunol Immunother; 2011 Aug; 60(8):1085-96. PubMed ID: 21526359
[TBL] [Abstract][Full Text] [Related]
12. Recombinant heat shock protein 70 functional peptide and alpha-fetoprotein epitope peptide vaccine elicits specific anti-tumor immunity.
Wang XP; Wang QX; Lin HP; Xu B; Zhao Q; Chen K
Oncotarget; 2016 Nov; 7(44):71274-71284. PubMed ID: 27713135
[TBL] [Abstract][Full Text] [Related]
13. Modified HPV16 E7/HSP70 DNA vaccine with high safety and enhanced cellular immunity represses murine lung metastatic tumors with downregulated expression of MHC class I molecules.
Li H; Ou X; Xiong J
Gynecol Oncol; 2007 Mar; 104(3):564-71. PubMed ID: 17081598
[TBL] [Abstract][Full Text] [Related]
14. A new purification method for enhancing the immunogenicity of heat shock protein 70-peptide complexes.
Gao Y; Chen X; Gao W; Yang Y; Ma H; Ren X
Oncol Rep; 2012 Dec; 28(6):1977-83. PubMed ID: 23007635
[TBL] [Abstract][Full Text] [Related]
15. Cancer cells containing nanoscale chemotherapeutic drugs generate antiovarian cancer-specific CD4+ T cells in peritoneal space.
Kim JE; Jang MJ; Lee JI; Chung YH; Jeong JH; Hung CF; Kim D
J Immunother; 2012 Jan; 35(1):1-13. PubMed ID: 22130157
[TBL] [Abstract][Full Text] [Related]
16. Immunological protection against HPV16 E7-expressing human esophageal cancer cell challenge by a novel HPV16-E6/E7 fusion protein based-vaccine in a Hu-PBL-SCID mouse model.
Lu Y; Zhang Z; Liu Q; Liu B; Song X; Wang M; Zhao X; Zhao Q
Biol Pharm Bull; 2007 Jan; 30(1):150-6. PubMed ID: 17202676
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
[TBL] [Abstract][Full Text] [Related]
18. Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor.
Wang XY; Li Y; Manjili MH; Repasky EA; Pardoll DM; Subjeck JR
Cancer Immunol Immunother; 2002 Aug; 51(6):311-9. PubMed ID: 12111119
[TBL] [Abstract][Full Text] [Related]
19. The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivo.
Harmala LA; Ingulli EG; Curtsinger JM; Lucido MM; Schmidt CS; Weigel BJ; Blazar BR; Mescher MF; Pennell CA
J Immunol; 2002 Nov; 169(10):5622-9. PubMed ID: 12421941
[TBL] [Abstract][Full Text] [Related]
20. Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110.
Manjili MH; Henderson R; Wang XY; Chen X; Li Y; Repasky E; Kazim L; Subjeck JR
Cancer Res; 2002 Mar; 62(6):1737-42. PubMed ID: 11912148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
